141 related articles for article (PubMed ID: 23520362)
1. Long-term accidental overdose of levetiracetam in an infant.
Özkale Y; Özkale M; Saygi S; Erol I
J Child Neurol; 2014 Jul; 29(7):959-61. PubMed ID: 23520362
[TBL] [Abstract][Full Text] [Related]
2. Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the Literature.
Kartal A
Clin Neuropharmacol; 2017; 40(5):217-218. PubMed ID: 28682928
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
4. An 11-year review of levetiracetam ingestions in children less than 6 years of age.
Lewis JC; Albertson TE; Walsh MJ
Clin Toxicol (Phila); 2014 Nov; 52(9):964-8. PubMed ID: 25283254
[TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive behavior induced by levetiracetam.
Fujikawa M; Kishimoto Y; Kakisaka Y; Jin K; Kato K; Iwasaki M; Nakasato N
J Child Neurol; 2015 Jun; 30(7):942-4. PubMed ID: 25008911
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
7. Safety of levetiracetam among infants younger than 12 months--Results from a European multicenter observational study.
Arzimanoglou A; Lösch C; Garate P; Bentz J
Eur J Paediatr Neurol; 2016 May; 20(3):368-75. PubMed ID: 26876768
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P
Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
Obeid M; Pong AW
Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
[TBL] [Abstract][Full Text] [Related]
11. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia associated with repeated use of levetiracetam.
Nasrallah K; Silver B
Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of levetiracetam.
Arroyo S; Crawford P
Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
[TBL] [Abstract][Full Text] [Related]
14. Overdose with levetiracetam: a case report and review of the literature.
Larkin TM; Cohen-Oram AN; Catalano G; Catalano MC
J Clin Pharm Ther; 2013 Feb; 38(1):68-70. PubMed ID: 22725831
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
16. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy: case reports.
Babtain FA
Clin Neuropharmacol; 2012; 35(4):201-2. PubMed ID: 22805231
[TBL] [Abstract][Full Text] [Related]
18. Hair loss with levetiracetam in five patients with epilepsy.
Zou X; Hong Z; Zhou D
Seizure; 2014 Feb; 23(2):158-60. PubMed ID: 24315496
[TBL] [Abstract][Full Text] [Related]
19. A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy.
Robins A; Patel M; Azim A
J Am Geriatr Soc; 2012 Jan; 60(1):159-60. PubMed ID: 22239298
[No Abstract] [Full Text] [Related]
20. Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine.
Alkhotani A; McLachlan RS
Seizure; 2012 Jun; 21(5):407-8. PubMed ID: 22524985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
